| Ident. | Authors (with country if any) | Title |
|---|
| 000000 (1998) |
A Rajput [Canada] ; S Birdi [Canada] | Epidemiology of Parkinson's disease |
| 000021 (2011) |
Wassilios Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
| 000024 (2010) |
Steven Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony Lang [Canada] ; Ira Shoulson [États-Unis] | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease |
| 000048 (2009) |
Connie Marras [Canada] ; Anthony Lang [Canada] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
| 000062 (1997) |
Z Wszolek [États-Unis] ; P Vieregge [Allemagne] ; R Uitti [Canada] ; T Gasser [Canada] ; O Yasuhara [Canada] ; P Mcgeer [Canada] ; K Berry [États-Unis] ; D Calne [Allemagne] ; F Vingerhoets [Allemagne] ; C Klein [Allemagne] ; R Pfeiffer [États-Unis] | German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia — Longitudinal observations |
| 000072 (1997) |
Robert Hauser [États-Unis] ; Theresa Zesiewicz [États-Unis] ; Stewart Factor [États-Unis] ; Mark Guttman [Canada] ; William Weiner [États-Unis] | Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness |
| 000073 (2007) |
Giovanni Fabbrini [Italie] ; Jonathan Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher Goetz [États-Unis] | Levodopa‐induced dyskinesias |
| 000110 (2010) |
Shen Lim [Canada, Malaisie] ; Anthony Lang [Canada] | The nonmotor symptoms of Parkinson's disease—An overview |
| 000111 (2011) |
Connie Marras [Canada] ; Michael Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 000119 (2008) |
C Olanow [États-Unis] ; Robert Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000123 (2011) |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 000127 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony Lang [Canada] ; C Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000129 (1994) |
C Lee [Canada] ; M Schulzer [Canada] ; E Mak [Canada] ; B Snow [Canada] ; J Tsui [Canada] ; S Clane [Canada] ; J Hammerstad [Canada] ; D Clane [Canada] | Clinical observations on the rate of progression of idiopathic parkinsonism |
| 000131 (2002) |
Sam Birdi [Canada] ; Ali Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada] | Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases |
| 000139 (1994) |
Olanow [États-Unis] ; S Fahn [États-Unis] ; M Muenter [États-Unis] ; H Klawans [États-Unis] ; H Hurtig [États-Unis] ; M Stern [États-Unis] ; I Shoulson [États-Unis] ; R Kurlan [États-Unis] ; J Grimes [Canada] ; J Jankovic [États-Unis] ; M Hoehn [États-Unis] ; C Markham [États-Unis] ; R Duvisin [États-Unis] ; O Reinmuth [États-Unis] ; H Leonard [États-Unis] ; E Ahlskog [États-Unis] ; R Feldman [États-Unis] ; L Hershey [États-Unis] ; M Yahr [États-Unis] | A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease |
| 000140 (2000) |
Paul Warrick [Canada] ; Christopher Dromey [Canada] ; Jonathan Irish [Canada] ; Lisa Durkin [Canada] ; Anthony Pakiam [Canada] ; Anthony Lang [Canada] | Botulinum Toxin for Essential Tremor of the Voice With Multiple Anatomical Sites of Tremor: A Crossover Design Study of Unilateral Versus Bilateral Injection |
| 000142 (2006) |
David Grimes [Canada] ; Fabin Han [Canada] ; Michel Panisset [Canada] ; Lemuel Racacho [Canada] ; Fengxia Xiao [Canada] ; Ruobing Zou [Canada] ; Kelly Westaff [Canada] ; Dennis Bulman [Canada] | Translated mutation in the Nurr1 gene as a cause for Parkinson's disease |
| 000155 (2009) |
Christine Klein [Allemagne, Canada] ; Susanne Schneider [Allemagne, Royaume-Uni] ; Anthony Lang [Canada] | Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond |
| 000172 (2010) |
Alberto Espay [États-Unis] ; Jennifer Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark Eckman [États-Unis] | Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis |
| 000175 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert Hauser [États-Unis] ; Anthony Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge Van [Pays-Bas] ; Guus Van [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000216 (2009) |
Bernard Ravina [États-Unis] ; Jordan Elm [États-Unis] ; Richard Camicioli [Canada] ; Peter Como [États-Unis] ; Laura Marsh [États-Unis] ; Joseph Jankovic [États-Unis] ; Daniel Weintraub [États-Unis] | The course of depressive symptoms in early Parkinson's disease |
